MAROTTA, SERENA
 Distribuzione geografica
Continente #
NA - Nord America 299
EU - Europa 99
AS - Asia 80
AF - Africa 16
Totale 494
Nazione #
US - Stati Uniti d'America 287
CN - Cina 40
IT - Italia 40
CI - Costa d'Avorio 16
IE - Irlanda 15
NL - Olanda 15
CA - Canada 12
IN - India 12
VN - Vietnam 8
PK - Pakistan 7
FI - Finlandia 6
GB - Regno Unito 6
DE - Germania 5
JP - Giappone 5
PS - Palestinian Territory 5
CH - Svizzera 2
FR - Francia 2
GR - Grecia 2
SG - Singapore 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BE - Belgio 1
ES - Italia 1
HU - Ungheria 1
SE - Svezia 1
Totale 494
Città #
Chandler 90
Ashburn 15
Nanjing 15
Amsterdam 12
Des Moines 12
Millbury 12
Beijing 9
Boston 9
Ottawa 9
Dong Ket 8
Princeton 8
Redwood City 7
Lawrence 5
Tokyo 5
Guangzhou 4
Glasgow 3
Napoli 3
Pune 3
Tampa 3
Utrecht 3
Basel 2
Bengaluru 2
Bologna 2
Bratislava 2
Cesano Boscone 2
Changsha 2
Chennai 2
Frankfurt am Main 2
Hamilton 2
Hebei 2
Manchester 2
Milan 2
Montegiorgio 2
Nanchang 2
New York 2
Palermo 2
Shanghai 2
Shenyang 2
Singapore 2
Thessaloniki 2
Tours 2
Tulkarm 2
Augusta 1
Bahawalpur 1
Baku 1
Borghetto Santo Spirito 1
Budapest 1
Campagna 1
Catania 1
Cava De' Tirreni 1
Dublin 1
Genova 1
Hyderabad 1
Indiana 1
Krefeld 1
Los Alamos 1
Los Angeles 1
Madrid 1
Montreal 1
Mountain View 1
Naples 1
Novara 1
Ostra 1
Pozzuoli 1
Redmond 1
Roccarainola 1
Seattle 1
Treviso 1
Totale 305
Nome #
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial 65
Eltrombopag for post-transplant cytopenias due to poor graft function 51
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY 41
Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future 38
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 36
Acute immune toxicity during anti-thymocyte globulin: That's CARPA! 36
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 36
CIRCULATING MEGAKARYOCYTE-DERIVED CELLS DETECTED BY FLOW CYTOMETRY AS MARKER OF AGGRESSIVE NEOPLASM OF MEGAKARYOCYTIC LINEAGE IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND ALLIED MALIGNANCIES PRESENTING AS PRIMARY MYELOFIBROSIS 32
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned 31
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for proximal complement inhibition? A position paper from the SAAWP of the EBMT 30
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High Dose Cyclophosphamide 29
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT 28
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria 28
Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions 25
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia 12
null 2
Totale 520
Categoria #
all - tutte 1.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 3 0 0 0
2019/202044 21 0 2 0 1 0 0 2 0 2 7 9
2020/202134 2 3 2 0 10 2 1 0 4 1 1 8
2021/2022101 0 0 0 0 0 3 0 1 14 9 38 36
2022/2023165 14 23 5 7 27 17 2 22 26 10 9 3
2023/2024135 5 25 6 3 26 23 8 25 14 0 0 0
Totale 520